The British Association of Dermatologists' Clinical Services Unit is responsible for developing guidance that focuses on the organisational aspects of delivery of dermatology healthcare services (service guidance). These differ from clinical guidelines which mainly deal with the interventions provided by clinicians to patients and the setting for their care. Service guidance provides the frameworks which help to deliver safe and effective care such as appropriate facilities, sufficient equipment and qualified staff for the clinical intervention.
Our approach to the development of current and pending service guidance is based on the core principles and methods guide set out by NICE for developing service guidance to meet its accreditation requirements.
In order to demonstrate the BAD has complied with its own processes we must formally undertake a public stakeholder consultation and respond accordingly to the feedback received before publication of our service guidance.
Therefore, we are seeking registration and feedback from interested stakeholder organisations, BAD membership and patient representatives on our Cutaneous Allergy Investigation Service Guidance and Standards.
In order to meet our process and NICE requirements for consultation we gratefully ask that all interested parties respond by 5pm on Thursday the 2nd May 2019, using the BAD stakeholder proforma.
Submission responses should be emailed to the attention of: Paul Callaghan at: email@example.com, or posted to the British Association of Dermatologists, Clinical Services Unit, Willan House, 4 Fitzroy Square, London, W1T 5HQ.
Please note: we are unable to accept responses from stakeholders outside of the provided proforma or after the advised date and time.